A pathway-based analysis on the effects of obstructive sleep apnea in modulating visceral fat transcriptome

Sleep

Volumn 36, Issue 1, 2013, Pages 23-30

  Gharib, Sina A ^a   Hayes, Amanda L ^b   Rosen, Michael J ^b   Patel, Sanjay R ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

Adipocyte; Metabolism; Microarray; Network; Sleep apnea

Indexed keywords

CYTOCHROME P450; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LINOLEIC ACID; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; PROTEASOME; STEROID HORMONE; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA;

ADULT; AGED; ARTICLE; BIOPSY; CELL CYCLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOWN REGULATION; FEMALE; GENE EXPRESSION PROFILING; HORMONE SYNTHESIS; HUMAN; HYPOXEMIA; INTRAABDOMINAL FAT; LYSOSOME; MALE; NUCLEOTIDE SEQUENCE; OXYGEN SATURATION; PRIORITY JOURNAL; RNA DEGRADATION; RNA EXTRACTION; RNA PROCESSING; SIGNAL TRANSDUCTION; SLEEP DISORDERED BREATHING; SUCROSE METABOLISM; UPREGULATION;

BIOPSY; CLUSTER ANALYSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; INTRA-ABDOMINAL FAT; MALE; MIDDLE AGED; NF-KAPPA B; PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS; POLYSOMNOGRAPHY; PROTEIN ARRAY ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA; SLEEP APNEA, OBSTRUCTIVE; TRANSCRIPTOME;

EID: 84871860125     PISSN: 01618105     EISSN: 15509109     Source Type: Journal    
DOI: 10.5665/sleep.2294     Document Type: Article

References (54)

1. Punjabi NM. The epidemiology of adult obstructive sleep apnea. Proc Am Thorac Soc 2008;5:136-43. (Pubitemid 351237871)
2. Punjabi NM, Caffo BS, Goodwin JL, et al. Sleep-disordered breathing and mortality: a prospective cohort study. PLoS Med 2009;6:e1000132.
3. Young T, Peppard PE, Taheri S. Excess weight and sleep-disordered breathing. J Appl Physiol 2005;99:1592-9. (Pubitemid 43014371)
4. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 2000;342:1378-84. (Pubitemid 30262394)
5. Punjabi NM, Sorkin JD, Katzel LI, Goldberg AP, Schwartz AR, Smith PL. Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 2002;165:677-82. (Pubitemid 34194756)
6. Ip MS, Lam KS, Ho C, Tsang KW, Lam W. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 2000;118:580-6.
7. Vgontzas AN, Papanicolaou DA, Bixler EO, et al. Sleep apnea and daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance, and hypercytokinemia. J Clin Endocrinol Metab 2000;85:1151-8. (Pubitemid 32269364)
8. Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK. Increases in leptin levels, sympathetic drive, and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 2000;279:H234-7. (Pubitemid 30616665)
9. Harsch IA, Schahin SP, Radespiel-Troger M, et al. Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 2004;169:156-62. (Pubitemid 38114528)
10. Yokoe T, Minoguchi K, Matsuo H, et al. Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 2003;107:1129-34. (Pubitemid 36297204)
11. Tilg H, Moschen AR. Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nat Rev Immunol 2006;6:772-83. (Pubitemid 44453463)
12. Hotamisligil GS, Shargill NS, Spiegelman BM. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 1993;259:87-91. (Pubitemid 23036092)
13. Hu E, Liang P, Spiegelman BM. AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem 1996;271:10697-703. (Pubitemid 26145805)
14. Randle PJ, Garland PB, Hales CN, Newsholme EA. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;1:785-9.
15. Ferrannini E, Barrett EJ, Bevilacqua S, DeFronzo RA. Effect of fatty acids on glucose production and utilization in man. J Clin Invest 1983;72:1737-47. (Pubitemid 14229053)
16. Sharma SK, Agrawal S, Damodaran D, et al. CPAP for the metabolic syndrome in patients with obstructive sleep apnea. N Engl J Med 2011;365:2277-86.
17. Liu Y, Patel S, Nibbe R, et al. Systems biology analyses of gene expression and genome wide association study data in obstructive sleep apnea. Pac Symp Biocomput:14-25.
18. Westbrook PR, Levendowski DJ, Cvetinovic M, et al. Description and validation of the apnea risk evaluation system: a novel method to diagnose sleep apnea-hypopnea in the home. Chest 2005;128:2166-75. (Pubitemid 41507555)
19. Bolstad BM, Irizarry RA, Astrand M, Speed TP. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics 2003;19:185-93. (Pubitemid 36181903)
20. Saeed AI, Sharov V, White J, et al. TM4: a free, open-source system for microarray data management and analysis. Biotechniques 2003;34:374-8. (Pubitemid 36184095)
21. Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 2005;102:15545-50. (Pubitemid 41528093)
22. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010;38 (Database issue):D355-60.
23. Ashburner M, Ball CA, Blake JA, et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet 2000;25:25-9. (Pubitemid 30257031)
24. Calvano SE, Xiao W, Richards DR, et al. A network-based analysis of systemic inflammation in humans. Nature 2005;437:1032-7. (Pubitemid 41486985)
25. Jensen LJ, Kuhn M, Stark M, et al. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res 2009;37(Database issue):D412-6.
26. Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 2008;3:1101-8. (Pubitemid 351818697)
27. Hartwell LH, Hopfield JJ, Leibler S, Murray AW. From molecular to modular cell biology. Nature 1999;402(6761 Suppl):C47-52.
28. Vidal M, Cusick ME, Barabasi AL. Interactome networks and human disease. Cell 2011;144:986-98.
29. Gottlieb DJ, Yenokyan G, Newman AB, et al. Prospective study of obstructive sleep apnea and incident coronary heart disease and heart failure: the sleep heart health study. Circulation 2010;122:352-60.
30. Redline S, Yenokyan G, Gottlieb DJ, et al. Obstructive sleep apnea-hypopnea and incident stroke: the sleep heart health study. Am J Respir Crit Care Med 2010;182:269-77.
31. Botros N, Concato J, Mohsenin V, Selim B, Doctor K, Yaggi HK. Obstructive sleep apnea as a risk factor for type 2 diabetes. Am J Med 2009;122:1122-7.
32. Hoffmann A, Natoli G, Ghosh G. Transcriptional regulation via the NF-kappaB signaling module. Oncogene 2006;25:6706-16. (Pubitemid 44657847)
33. Lumeng CN, Saltiel AR. Inflammatory links between obesity and metabolic disease. J Clin Invest 2011;121:2111-7.
34. Baker RG, Hayden MS, Ghosh S. NF-kappaB, inflammation, and metabolic disease. Cell Metab 2011;13:11-22.
35. Htoo AK, Greenberg H, Tongia S, et al. Activation of nuclear factor kappaB in obstructive sleep apnea: a pathway leading to systemic inflammation. Sleep Breath 2006;10:43-50. (Pubitemid 44193436)
36. Ryan S, Taylor CT, McNicholas WT. Selective activation of inflammatory pathways by intermittent hypoxia in obstructive sleep apnea syndrome. Circulation 2005;112:2660-7. (Pubitemid 41532603)
37. Goldfine AB, Fonseca V, Jablonski KA, Pyle L, Staten MA, Shoelson SE. The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial. Ann Intern Med 2010;152:346-57.
38. Kopp E, Ghosh S. Inhibition of NF-kappa B by sodium salicylate and aspirin. Science 1994;265:956-9.
39. Lihn AS, Bruun JM, He G, Pedersen SB, Jensen PF, Richelsen B. Lower expression of adiponectin mRNA in visceral adipose tissue in lean and obese subjects. Mol Cell Endocrinol 2004;219:9-15. (Pubitemid 38638516)
40. Kursawe R, Narayan D, Cali AM, et al. Downregulation of ADIPOQ and PPARgamma2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis. Obesity (Silver Spring) 2010;18:1911-7.
41. Weyer C, Funahashi T, Tanaka S, et al. Hypoadiponectinemia in obesity and type 2 diabetes: close association with insulin resistance and hyperinsulinemia. J Clin Endocrinol Metab 2001;86:1930-5. (Pubitemid 32472900)
42. Hotta K, Funahashi T, Arita Y, et al. Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 2000;20:1595-9. (Pubitemid 30353893)
43. Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab 2002;87:2764-9. (Pubitemid 34655342)
44. Finley D. Recognition and processing of ubiquitin-protein conjugates by the proteasome. Annu Rev Biochem 2009;78:477-513.
45. Wing SS. The UPS in diabetes and obesity. BMC biochemistry 2008;9 Suppl 1:S6.
46. Lefebvre B, Benomar Y, Guedin A, et al. Proteasomal degradation of retinoid X receptor alpha reprograms transcriptional activity of PPARgamma in obese mice and humans. J Clin Invest 2010;120:1454-68.
47. Bengoechea-Alonso MT, Ericsson J. The ubiquitin ligase Fbxw7 controls adipocyte differentiation by targeting C/EBPalpha for degradation. Proc Natl Acad Sci U S A 2010;107:11817-22.
48. Rui L, Yuan M, Frantz D, Shoelson S, White MF. SOCS-1 and SOCS-3 block insulin signaling by ubiquitin-mediated degradation of IRS1 and IRS2. J Biol Chem 2002;277:42394-8. (Pubitemid 35257562)
49. Sakai T, Sakaue H, Nakamura T, et al. Skp2 controls adipocyte proliferation during the development of obesity. J Biol Chem 2007;282:2038-46. (Pubitemid 47076733)
50. Hoeller D, Dikic I. Targeting the ubiquitin system in cancer therapy. Nature 2009;458:438-44.
51. Ernst R, Claessen JH, Mueller B, et al. Enzymatic blockade of the ubiquitin-proteasome pathway. PLoS Biol 2011;8:e1000605.
52. Gharib SA, Khalyfa A, Abdelkarim A, et al. Intermittent hypoxia activates temporally coordinated transcriptional programs in visceral adipose tissue. J Mol Med (Berl) 2012;90:435-45.
53. Gharib SA, Khalyfa A, Abdelkarim A, Bhushan B, Gozal D. Integrative miRNA-mRNA profiling of adipose tissue unravels transcriptional circuits induced by sleep fragmentation. PLoS One 2012;7:e37669.
54. Chen ZJ. Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 2005;7:758-65.